An Introduction to Drug Disposition: The Basic Principles of Absorption, Distribution, Metabolism, and Excretion

A knowledge of the fate of a drug, its disposition (absorption, distribution, metabolism, and excretion, known by the acronym ADME) and pharmacokinetics (the mathematical description of the rates of these processes and of concentration-time relationships), plays a central role throughout pharmaceutical research and development. These studies aid in the discovery and selection of new chemical entities, support safety assessment, and are critical in defining conditions for safe and effective use in patients. ADME studies provide the only basis for critical judgments from situations where the behavior of the drug is understood to those where it is unknown: this is most important in bridging from animal studies to the human situation. This presentation is intended to provide an introductory overview of the life cycle of a drug in the animal body and indicates the significance of such information for a full understanding of mechanisms of action and toxicity.

[1]  P. Evans,et al.  Genetic Factors in Drug Therapy: Clinical and Molecular Pharmacogenetics , 1994 .

[2]  W. Stott.  Chemically induced proliferation of peroxisomes: implications for risk assessment. , 1988, Regulatory toxicology and pharmacology : RTP.

[3]  J. Caldwell.  Chapter 5 – Comparative Aspects of Detoxication in Mammals , 1980 .

[4]  Drug Oxidations,et al.  Microsomes, drug oxidations, and drug toxicity , 1982 .

[5]  J. Caldwell.  Conjugation Mechanisms of Xenobiotic Metabolism: Mammalian Aspects , 1986 .

[6]  G R Wilkinson,et al.  Clearance approaches in pharmacology. , 1987, Pharmacological reviews.

[7]  Z. Gatmaitan,et al.  Two distinct mechanisms for bilirubin glucuronide transport by rat bile canalicular membrane vesicles. Demonstration of defective ATP-dependent transport in rats (TR-) with inherited conjugated hyperbilirubinemia. , 1992, The Journal of clinical investigation.

[8]  P. Jansen,et al.  Inhibition of glutathione-conjugate secretion from isolated hepatocytes by dipolar bile acids and other organic anions. , 1991, The Biochemical journal.

[9]  R. Pearson,et al.  Application of the Principle of Hard and Soft Acids and Bases to Organic Chemistry , 1967 .

[10]  C. Falany.  Molecular enzymology of human liver cytosolic sulfotransferases. , 1991, Trends in pharmacological sciences.

[11]  D A Smith,et al.  Speculations on the substrate structure-activity relationship (SSAR) of cytochrome P450 enzymes. , 1992, Biochemical pharmacology.

[12]  Z. Gatmaitan,et al.  Rat liver canalicular membrane vesicles contain an ATP-dependent bile acid transport system. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[13]  I. West.  What determines the substrate specificity of the multi-drug-resistance pump? , 1990, Trends in biochemical sciences.

[14]  W. Flamm,et al.  The human relevance of the renal tumor-inducing potential of d-limonene in male rats: implications for risk assessment. , 1991, Regulatory toxicology and pharmacology : RTP.

[15]  J. Caldwell,et al.  The toxicological significance of xenobiotic metabolism. , 1990, Food additives and contaminants.

[16]  J. Depierre,et al.  Microsomal epoxide hydrolase. Properties, regulation and function. , 1983, Biochimica et biophysica acta.

[17]  E. Myhre,et al.  Clinical Pharmacokinetics of Methyldopa , 1982, Clinical pharmacokinetics.

[18]  E C Miller,et al.  Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1'-sulfoöxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1'-hydroxysafrole in mouse liver. , 1983, Cancer research.

[19]  F. Suchy,et al.  The rat liver ecto-ATPase is also a canalicular bile acid transport protein. , 1993, The Journal of biological chemistry.

[20]  C. Ioannides,et al.  Structural requirements for substrates of cytochromes P-450 and P-448. , 1987, Chemico-biological interactions.

[21]  L. Koymans,et al.  Cytochromes P450: their active-site structure and mechanism of oxidation. , 1993, Drug metabolism reviews.

[22]  Y. Sawada,et al.  Kinetic analysis of hepatobiliary transport of vincristine in perfused rat liver. Possible roles of P-glycoprotein in biliary excretion of vincristine. , 1992, Journal of hepatology.

[23]  M. Kietzmann.  Conjugation Reactions in Drug Metabolism: Mulder, G.J. (Ed.), X+413 pp., London, New York, Philadelphia: Taylor and Francis (1990) , 1991 .

[24]  C. Ioannides,et al.  The cytochromes P-448--a unique family of enzymes involved in chemical toxicity and carcinogenesis. , 1987, Biochemical pharmacology.

[25]  D. Jerina,et al.  Stereoselective metabolism of polycyclic aromatic hydrocarbons to carcinogenic metabolites , 1985 .

[26]  P. van Bladeren,et al.  The role of glutathione conjugation in the mutagenicity of 1,2-dibromoethane. , 1980, Biochemical pharmacology.

[27]  D. Smith,et al.  Species differences in metabolism and pharmacokinetics: are we close to an understanding? , 1991, Drug metabolism reviews.

[28]  M. Frimmer.  What we have learned from phalloidin. , 1987, Toxicology letters.

[29]  S A van Acker,et al.  A predictive model for substrates of cytochrome P450-debrisoquine (2D6). , 1992, Chemical research in toxicology.

[30]  F. Guengerich.  The 1992 Bernard B. Brodie Award Lecture. Bioactivation and detoxication of toxic and carcinogenic chemicals. , 1993, Drug metabolism and disposition: the biological fate of chemicals.

[31]  Z. Gatmaitan,et al.  ATP-dependent organic anion transport system in normal and TR- rat liver canalicular membranes. , 1992, The American journal of physiology.

[32]  W. Stremmel,et al.  Role of plasma membrane ligand‐binding proteins in the hepatocellular uptake of albumin‐bound organic anions , 1987, Hepatology.

[33]  J. Swenberg,et al.  The comparative pathobiology of α2u-globulin nephropathy , 1989 .

[34]  A. Jones,et al.  The human phenolsulphotransferase polymorphism is determined by the level of expression of the enzyme protein. , 1993, The Biochemical journal.

[35]  J. Caldwell,et al.  The metabolism and disposition of fenofibrate in rat, guinea pig, and dog. , 1988, Drug metabolism and disposition: the biological fate of chemicals.

[36]  S. Thorgeirsson,et al.  Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen. , 1974, Pharmacology.

[37]  M. Frimmer.  Uptake of Foreign Cyclopeptides by Liver Cells , 1989 .

[38]  O. James.  Drugs and the ageing liver. , 1985, Journal of hepatology.

[39]  B. Testa.  CHAPTER 5 – Nonenzymatic Biotransformation , 1983 .

[40]  F. Guengerich,et al.  Mechanisms of cytochrome P‐450 catalysis , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  D W Nebert,et al.  The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. , 1991, DNA and cell biology.

[42]  G. Benness.  The Excretory Function of Bile, R.L. Smith. Chapman & Hall, London (1973), A$14.00. , 1977 .

[43]  L. Lehman-Mckeeman.  Lysosomal degradation of ?2u-globulin and ?2u-globulin-xenobiotic conjugates*1 , 1990 .

[44]  M. Parker,et al.  Structure and function of glutathione S-transferases. , 1994, Biochimica et biophysica acta.

[45]  A. S. Gross,et al.  The genetic polymorphism of debrisoquine/sparteine metabolism--clinical aspects. , 1990, Pharmacology & therapeutics.

[46]  R. Smith,et al.  The excretory function of bile : the elimination of drugs and toxic substances in bile , 1973 .

[47]  K. Schenck-Gustafsson,et al.  Digoxin‐verapamil interaction: Reduction of biliary but not renal digoxin clearance in humans , 1991, Clinical pharmacology and therapeutics.

[48]  K. Ziegler,et al.  The transport of bile acids in liver cells. , 1988, Biochimica et biophysica acta.

[49]  A. Y. Lu,et al.  N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[50]  V. Feron,et al.  The long‐term study in rodents for identifying carcinogens: Some controversies and suggestions for improvements , 1986, Journal of applied toxicology : JAT.

[51]  W. Levin,et al.  Purification and characterization of hepatic microsomal cytochrome P-450. , 1990, Pharmacology & therapeutics.

[52]  R. Skoda,et al.  The genetic polymorphism of debrisoquine/sparteine metabolism-molecular mechanisms. , 1990, Pharmacology & therapeutics.

[53]  J. Depierre,et al.  Cytosolic epoxide hydrolase. , 1988, Chemico-biological interactions.

[54]  Z. Gatmaitan,et al.  The function of Gp170, the multidrug resistance gene product, in rat liver canalicular membrane vesicles. , 1989, The Journal of biological chemistry.

[55]  Z. Gatmaitan,et al.  Two Distinct Mechanisms for Bilirubin Glucuronide Transport by Rat Bile Canalicular Membrane Vesicles , 1992 .